BioSpace News Archive

FDA

Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease

Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, is pleased to have supported Biogen with its efforts to obtain FDA accelerated approval of Aducanumab for Alzheimer’s disease.

June 16, 2021
·
3 min read
Business

Pharmaceutical Associates, Inc. appoints Dr. Suketu Sanghvi as Chief Scientific Officer

Pharmaceutical Associates, Inc. (PAI) announced today the appointment of Dr. Suketu Sanghvi as Chief Scientific Officer.

June 16, 2021
·
2 min read
PharmaTher To Present At The H.C. Wainwright Psychedelics In Psychiatry And Beyond Virtual Conference

PharmaTher Holdings Ltd. today announced that Fabio Chianelli, Chief Executive Officer, will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17, 2021.

June 16, 2021
·
3 min read
BioForest

Impel NeuroPharma to Present at the Raymond James Human Health Innovation Conference

Impel NeuroPharma today announced that the Company will present a corporate overview at the Raymond James Human Health Innovations Conference on Wednesday, June 23, 2021 at 3:20 p.m. ET.

June 16, 2021
·
1 min read
Business

Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M)

Apexigen, Inc. today announced an agreement to initiate a collaborative Phase 2 clinical study evaluating sotigalimab,

June 16, 2021
·
4 min read
Motus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation

Motus GI Holdings, Inc. announced today enrollment of the first patients in the European Union (EU) study of the Pure-Vu System.

June 16, 2021
·
6 min read
Drug Development

Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine in TP53 Mutant AML Meets Complete Remission Primary Efficacy Endpoint

Aprea Therapeutics, Inc. today announced that the Phase 1/2 trial evaluating the frontline treatment of eprenetapopt with venetoclax and azacitidine in patients with TP53 mutant AML has met the pre-specified primary efficacy endpoint of complete remission rate.

June 16, 2021
·
6 min read
Business

INSPIRA-Technologies Announces New Medical Advisory Board Member - Dr. Avraham Abutbul - Specialist in Internal Medicine, General Intensive Care Medicine and Pulmonary Medicine

INSPIRA Technologies Ltd., a leader in breakthrough respiratory medical technology, announced that Avraham Abutbul, MD, head of Hadassah Medical Center for COPD, has joined the clinical advisory board of INSPIRA-Technologies.

June 16, 2021
·
2 min read
Biotech Beach

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology

Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology.

June 16, 2021
·
3 min read
Biotech Bay

New study confirms that social determinants of health challenges are prevalent among commercially-insured populations

Castlight Health, Inc. (NYSE: CSLT), a leading health navigation platform, today announced the results of a new study on the impact of social determinants of health (SDoH) factors on workforce health.

June 16, 2021
·
4 min read